# The Safety and Effectiveness of NV-A01 in Glioma Patients

> **NCT06193538** · PHASE1 · UNKNOWN · sponsor: **First Affiliated Hospital of Wannan Medical College** · enrollment: 15 (estimated)

## Conditions studied

- Advanced Glioblastoma Patients

## Interventions

- **DRUG:** Recombinant NV-A01 adenovirus injection

## Key facts

- **NCT ID:** NCT06193538
- **Lead sponsor:** First Affiliated Hospital of Wannan Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-14
- **Primary completion:** 2024-12
- **Final completion:** 2025-07
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06193538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06193538, "The Safety and Effectiveness of NV-A01 in Glioma Patients". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06193538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*